Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 45Terminated 11Recruiting 4Unknown 3Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Periampullary Tumors 1Gastric NET 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Octreotide × Clear all
NCT06085976 2023-10-17

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Unknown
62 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03812939 2019-01-23

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Peking Union Medical College Hospital

Unknown
30 enrolled
Gastrointestinal

Gastric NET

NCT02920567 2016-09-30

Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion

Saint Vincent's Hospital, Korea

Phase NA Unknown
282 enrolled

Periampullary Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡